A single threatening experience may change the behavior of an animal in a long-lasting way and elicit generalized behavioral responses to a novel threatening situation that is unrelated to the original aversive experience. Electrical stimulation (ES) of the dorsal periaqueductal gray (dPAG) produces a range of defensive reactions, characterized by freezing, escape, and post-stimulation freezing (PSF). The latter reflects the processing of ascending aversive information to prosencephalic structures, including the central nucleus of the amygdala (CeA), which allows the animal to evaluate the consequences of the aversive situation. This process is modulated by substance P (SP) and its preferred receptor, neurokinin 1 (NK1). The ventral hippocampus (VH) has been associated with the processing of aversive information and expression of emotional reactions with negative valence, but the participation of the VH in the expression of these defensive responses has not been investigated. The VH is rich in NK1 receptor expression and has a high density of SP-containing fibers. The present study examined the role of NK1 receptors in the VH in the expression of defensive responses and behavioral sensitization that were induced by dPAG-ES. Rats were implanted with an electrode in the dPAG for ES, and a cannula was implanted in the VH or CeA for injections of vehicle (phosphate-buffered saline) or the NK1 receptor antagonist spantide (100 pmol/0.2 μL. Spantide reduced the duration of PSF that was evoked by dPAG-ES, without changing the aversive freezing or escape thresholds. One and 7 days later, exploratory behavior was evaluated in independent groups of rats in the elevated plus maze (EPM). dPAG-ES in rats that received vehicle caused higher aversion to the open arms of the EPM compared with rats that did not receive dPAG stimulation at both time intervals. Injections of spantide in the VH or CeA prevented the proaversive effects of dPAG-ES in the EPM only 1 day later. These findings suggest that NK1 receptors are activated in both the VH and CeA during the processing of aversive information that derives from dPAG-ES. As previously shown for the CeA, SP/NK1 receptors in the VH are recruited during PSF that is evoked by dPAG-ES, suggesting that a 24-h time window is susceptible to interventions with NK1 antagonists that block the passage of aversive information from the dPAG to higher brain areas.
Introduction
Recent years have seen growing interest in the ways in which emotional stress is controlled at the neural level, the behavioral impact, and the development of such psychopathologies as posttraumatic stress disorder (PTSD; Calfa, Bussolino, & Molina, 2007; Day, Reed, & Stevenson, 2016; Ryoke, Yamada, & Ichitani, 2014; Wiedenmayer, 2004) . A single aversive experience can lead to long-lasting behavioral changes (Ryoke et al., 2014; Wiedenmayer, 2004) , such as the overgeneralization of anxiety and fear in response to innocuous stimuli or a novel threatening situation that is unrelated to the original aversive experience (Day et al., 2016; Wiedenmayer, 2004) .
Imminent threatening stimuli trigger alertness, freezing, and escape responses (Maren, 2007) . Electrical stimulation (ES) of the dorsal periaqueductal gray (dPAG; induces defensive reactions that resemble those that are exhibited by animals when they are confronted with natural predators (Brandao, Anseloni, Pandossio, De Araujo, & Castilho, 1999; Fanselow, 1991; Fernandez de Molina & Hunsperger, 1959; Olds & Olds, 1962) . It also induces post-stimulation freezing (PSF; ) that reflects the processing of ascending aversive information to prosencephalic structures, thus allowing the animal to evaluate the consequences of aversive situations (Carvalho, Santos, Bassi, & Brandao, 2013; Carvalho, Santos, & Brandao, 2015; Martinez, de Oliveira, & Brandão, 2006) . Previous findings indicate that a single dPAG-ES event can generate behavioral sequelae, including the development of anxiety-like behavior and the overgeneralization of fear (Carvalho et al., 2015) .
Stressful events activate limbic structures, such as the hippocampus and amygdala, leading to the persistence of alterations in emotional states that are associated with PTSD (Calfa et al., 2007; Wiedenmayer, 2004) . Some lines of evidence indicate that the hippocampus presents functional segregation in its dorsoventral axis. The ventral hippocampus (VH) appears to modulate anxiety-like behavior, and the dorsal hippocampus (DH) is more involved in memory processes (Bannerman et al., 2004; Bertoglio, Joca, & Guimaraes, 2006; Pentkowski, Blanchard, Lever, Litvin, & Blanchard, 2006) . Recent data show that the VH and amygdala are also recruited during dPAG-dependent defensive reactions. Electrolytic lesions of this VH subregion attenuated freezing and escape responses that were produced by dPAG-ES, and the inactivation of distinct nuclei of the amygdala reduced the duration of PSF (Ballesteros, de Oliveira Galvao, Maisonette, & LandeiraFernandez, 2014; Martinez et al., 2006) .
The neuropeptide substance P (SP) is involved in the regulation of behavioral processes, including reinforcement, learning, memory, fear, and anxiety (Chahl, 2006; Ebner, Rupniak, Saria, & Singewald, 2004; Hasenohrl et al., 2000; Huston & Hasenohrl, 1995) . We found that SP may be involved in fear memory that is generated by dPAG-ES (Carvalho et al., 2013 (Carvalho et al., , 2015 . Among the three neurokinin (NK) receptors (NK1, NK2, and NK3), SP has higher affinity for NK1 receptors (Hokfelt, Bartfai, & Bloom, 2003; Mantyh, 2002; Mussap, Geraghty, & Burcher, 1993; Quartara & Maggi, 1998; Yu, Zeng, Shu, Liu, & Li, 2014) . The VH is rich in SP and NK1 receptor expression (Borhegyi & Leranth, 1997; Maeno, Kiyama, & Tohyama, 1993; Quartara & Maggi, 1998 ), but unknown is whether they modulate the expression of defensive behaviors that are evoked by dPAG-ES and behavioral sensitization that is encoded by this aversive stimulation. The present study evaluated the effects of a direct infusion of the NK1 receptor antagonist spantide in the VH and central nucleus of the amygdala (CeA) on freezing, escape, and PSF responses that were elicited by dPAG-ES in rats. The aversive consequences of dPAG-ES on fear memory were assessed 1 and 7 days later by analyzing exploratory behavior in the elevated plus maze (EPM; Experiment 1). According to several studies, this time window is sufficient for memory consolidation (Colley & Routtenberg, 1993; Izquierdo & Medina, 1997; Izquierdo et al., 2006) . In Experiments 2 and 3, rats received injections of spantide into the VH or CeA, respectively, to examine modulation of the long-lasting consequences of dPAG-ES by NK1 receptors. The 100 pmol dose of spantide was chosen based on previous studies from this laboratory that evaluated the 10-100 pmol dose range for this NK1 antagonist (Carvalho et al., 2013 (Carvalho et al., , 2015 .
Materials and methods

Animals
The experiments were performed in accordance with the Brazilian Society of Neuroscience and Behavior (SNeC) Guidelines for the Care and Use of Laboratory Animals. The procedures were approved by the Committee on Animal Research and Ethics (CEUA) of the University of Sao Paulo (No. 09.1.84.54.7). All efforts were made to minimize the number of animals used and their suffering. A total of 102 male Wistar rats from the animal house of the University of São Paulo, Ribeirão Preto campus, weighing 250-270 g, were used. The rats were housed in groups of four animals per Plexiglas cage with food and water available ad libitum in a temperature-controlled room (23°C ± 1°C) under a 12 h/12 h light/dark cycle (lights on at 7:00 AM). The rats were transported to the experimental room in their home cages and left undisturbed for 1 h prior to testing. In Experiment 1, the rats were randomly assigned to one of four groups that were subjected to procedures for the determination of aversive thresholds (freezing and escape) and PSF, followed by the EPM test: SHAM (no-ES), 1 day, 7 days, and 14 days. For Experiments 2 and 3, the rats were assigned to one of five groups for each injected brain structure: SHAM (no-ES), PBS-1 day, spantide-1 day, PBS-7 days, and spantide-7 days. The SHAM groups were not exposed to dPAG-ES, serving as a control for the EPM test.
Surgery
The rats were intraperitoneally anesthetized with ketamine/xylazine (100/7.5 mg/kg) (Agener União, Embu-Guaçu, SP, Brazil) and fixed in a stereotaxic frame (David Kopf, Tujunga, CA, USA). The upper incisor bar was set 3.3 mm below the interaural line, such that the skull was horizontal between bregma and lambda. After scalp anesthesia with 2% lidocaine (S.S. White Artigos Dentários, São Paulo, Brazil), the skull was surgically exposed, and a unilateral guide cannula was implanted over the right VH. According to the atlas of Paxinos and Watson (2007) , with bregma serving as the reference point, the right VH (anterior/posterior [AP], 4.6 mm; medial/lateral [ML], 5.0 mm; dorsal/ ventral [DV], 2.0 mm) and right CeA (AP, 1.9 mm; ML, 4.1 mm; DV, 5.0 mm) were reached with a guide cannula (12 mm). A bipolar brain electrode was then implanted in the midbrain, aimed at the dPAG. The electrodes consisted of two twisted stainless-steel wires (50 μm diameter each) that were insulated except at the cross-section of the tip. The electrode was introduced at a 22°angle inclined medially, with lambda serving as the reference for each plane (AP, 0 mm; ML, 1.9 mm; DV, 5.3 mm). For all groups, the cannulae and electrode were fixed to the skull with acrylic resin and two stainless-steel anchor screws. Each guide cannula was sealed with a stainless-steel wire to prevent obstruction. At the end of surgery, the rats received an intramuscular injection of penicillin G benzathine (Pentabiotic, 600,000 IU, 0.2 ml; Fort Dodge, Campinas, SP, Brazil) and subcutaneous injection of the antiinflammatory and analgesic flunixin meglumine (Banamine, 2.5 mg/kg; Schering-Plough, Cotia, SP, Brazil). The rats were then returned to their home cages and allowed to recover for 5 days.
Drug and microinjection procedure
Spantide (Sigma-Aldrich, St Louis, MO, USA) was dissolved in phosphate-buffered saline (PBS) solution (0.1 M) shortly before use. The rats received spantide (100 pmol/0.2 μL) in the VH or CeA, and control rats received the same volume of PBS. The doses and schedule of the injections were based on previous studies (Carvalho et al., 2013 (Carvalho et al., , 2015 . The infusions were delivered in a constant volume of 0.2 μL over 1 min using an infusion pump (Harvard Apparatus, Holliston, MA, USA). Slow administration of small volumes (0.004 μL/s) of drug solution was employed to minimize the physical disruption of tissue at the injection site. A thin dental needle (0.3 mm outer diameter) that was attached via polyethylene tubing to a 5 μL Hamilton syringe was introduced through each guide cannula. The injection needle protruded 5.0 mm for the VH and 3.0 mm for the CeA below the ventral tip of the implanted guide cannula. The displacement of an air bubble inside the polyethylene tubing that connected the syringe to the injection needle was used to monitor the microinjections. The injection needles were left in place for 1 min after the end of the infusion to allow for diffusion.
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Neurobiology of Learning and Memory 148 (2018) 60-68 2.4. Electrical stimulation of the dPAG Five days after surgery, the animals were placed in a square Plexiglas box (25 cm × 20 cm × 20 cm) in an illuminated room with a 40 W fluorescent lamp (80 lx at the level of the box floor). The animals were allowed a 10-min period of acclimation in the enclosure at the beginning of each session. Afterward, the dPAG was electrically stimulated by means of a sine-wave stimulator (DelVecchio, Ribeirão Preto, SP, Brazil). The stimulation current was monitored by measuring the voltage drop across a 1-kΩ resistor with an oscilloscope (Minipa, Houston, TX, USA). Brain stimulation (60 Hz sine wave for 10 s) was presented at pseudorandom intervals (30-120 s), with the current intensity increasing by 5 μA steps to determine the thresholds for freezing and escape responses. The freezing threshold was defined as the lowest intensity that produced the absence of movement, except movements related to respiration. The intensity of current that produced running and/or jumping was considered the escape threshold. Animals with an escape threshold > 120 μA (peak-to-peak) were removed from the experiment. To investigate behavior that persisted after escape, the animals remained in the experimental box for another 8 min, without any stimulation, during which the duration of PSF was recorded. For Experiment 1, the dPAG-ES procedure was conducted to determine the aversive thresholds for freezing, escape, and PSF (Carvalho et al., 2013 (Carvalho et al., , 2015 . One, 7, and 14 days later, exploratory behavior was evaluated in the EPM. For Experiments 2 and 3, the rats also underwent the dPAG-ES procedure and received local injections of spantide in the CeA or VH. Five minutes after the local drug injections, freezing and escape thresholds and PSF were determined again. One and 7 days later, exploratory behavior was assessed in the EPM in these independent groups of rats.
Elevated plus maze
The EPM was a modified version of the previously described apparatus (Pellow, Chopin, File, & Briley, 1985) . The two opposing closed arms were 50 cm × 10 cm, enclosed by 40-cm-high walls with no roof.
The two opposing open arms were also 50 cm × 10 cm with a 0.5-cm high Plexiglas edge on either side and at the end of each arm. The central area was 10 cm × 10 cm. The closed arm walls were constructed with urethane-coated wood and lined with Plexiglas. The floor of the maze was covered with a thin layer of vulcanized black rubber to facilitate intertrial cleaning. The apparatus was elevated 50 cm above the floor on a wooden stand that was hidden from view, and the floor under the stand was covered with black cloth to minimize possible height cues. The rats were individually placed in the center of the maze, facing a closed arm, and allowed 5-min of free exploration. Before the next rat was tested, the maze was cleaned with a 20% ethanol solution. Behaviors were recorded by a video camera (Everfocus, Duarte, CA, USA) that was positioned above the maze. The signal was relayed to a monitor in another room via a closed-circuit TV camera. The apparatus was located inside of a room with constant background noise (50 dB), and the luminosity at the level of the open arms was 30 lx. The videos were subsequently scored by a trained observer who was blind to the drug condition using Etholog 2.2.5 ethological analysis software (São Paulo, Brazil; Ottoni, 2000) . The behavior of each animal in the maze was analyzed using standard measures, including the number of open and closed arm entries (an arm entry was defined as all four paws entering an arm), total arm entries, and the time spent in each section of the maze (Carvalho et al., 2013 (Carvalho et al., , 2015 .
Histology
Upon conclusion of the experiments, to confirm the placements of the microinjection sites, 0.2 μL of Evans blue (2%) was microinjected in the VH or CeA. The brains were then removed from the skulls, maintained in 10% formalin for 1 week, and then cryoprotected in 30% sucrose until soaked. Coronal 60-μm slices were cut, mounted on gelatin-coated slides, and stained with Cresyl violet (5%), which allowed localization of the microinjection sites according to the atlas of Paxinos and Watson (2007) . A total of 19 rats were excluded from the analysis because of inappropriate cannula or electrode placement.
Statistical analysis
Prism 6.0 software for Windows (GraphPad, San Diego, CA, USA) was used for the data analysis. The data are expressed as mean ± standard error of the mean (SEM). For Experiment 1, one-way analysis of variance (ANOVA) was used to assess exploratory behavior in the EPM in rats that were exposed to dPAG-ES 1, 7, or 14 days before this behavioral test. For Experiments 2 and 3, two-way repeated-measures ANOVA was used to assess the effects of the drug injections in the VH and CeA on defensive responses (freezing and escape and PSF time) that were induced by dPAG-ES, with treatment (PBS and spantide) and condition (pre-and post-injection) as factors. One-way ANOVA was used to assess the effects of the drug injections in the VH and CeA on behavior in the EPM in rats that were exposed to dPAG-ES 1 or 7 days before the behavioral test. Significant effects in the ANOVAs were followed by Bonferroni's post hoc test. Values of p < .05 were considered statistically significant.
Results
Experiment 1: consequences of dPAG-ES on exploratory behavior in the EPM
Only rats in which the tips of the electrodes were located within the dPAG were used in this study (Fig. 1A) . The values (mean ± SEM) of the freezing and escape thresholds in response to dPAG-ES and PSF time at 1 day, 7 days, and 14 days are shown in Table 1 . The one-way ANOVA revealed no differences among groups (F 2,12 = 2.13 and 1.91, p > .05, for freezing and escape thresholds, respectively; F 2,12 = 0.46, p > .05, for PSF). For the EPM data, a one-way ANOVA was first applied to the SHAM (no-ES) data for all of the experimental groups (1 day, 7 days, and 14 days). This analysis allowed us to pool all of these data together to form a control group because no differences were observed in the number of open-arm entries (F 2,12 = 0.71, p > .05) and closed-arm entries (F 2,12 = 1.63, p > .05) and the percent time spent on the open arms relative to total time (F 2,12 = 1.60, p > .05; Table 2 ). The control groups in this one-way ANOVA presented significant differences in the number of open-arm entries (F 3,33 = 12.72, p < .05) and percent time spent on the open arms relative to total time (F 3,33 = 4.15, p < .05) at all three time points (1, 7, and 14 days after dPAG-ES; Fig. 2 ). The post hoc comparisons revealed that the group of rats that was subjected to the EPM 1 day, 7 days, and 14 days after dPAG-ES exhibited fewer open-arm entries and a decrease in the percent time spent on the open arms compared with the SHAM group ( Fig. 2B and D, respectively) . This analysis also revealed no significant differences in the number of closed-arm entries (F 3,33 = 2.41, p > .05; Fig. 2C ).
3.2. Experiment 2: influence of spantide injections in the VH on the effects of dPAG-ES on behavior in the EPM 1 and 7 days later Only rats in which the tips of the electrodes were located within the dPAG and the injection needles were within the VH were used in this study (Fig. 1B) . Two-way repeated-measures ANOVA was used to assess the effects of the drug injections in the VH on defensive responses (freezing and escape and PSF time) that were induced by dPAG-ES, with treatment (PBS and spantide) and condition (pre-and post-injection) as factors. To the freezing threshold data, the two-way repeated-measures ANOVA revealed no significant effects of treatment (F 1,34 = 2.58, p > .05) or condition (F 1,34 = 1.01, p > .05) and no treatment × condition interaction (F 1,34 = 3.45, p > .05; Fig. 3B ). The same analysis was applied to the escape threshold data, revealing a significant effect of condition (F 1,34 = 6.47, p < .05) but not treatment (F 1,34 = 3.02, p > .05) and no treatment × condition interaction (F 1,34 = 0.80, p > .05; Fig. 3C ). However, when the same analysis was performed for the duration of PSF when dPAG-ES at the escape threshold had ceased indicated significant effects of treatment (F 1,34 = 8.76, p < .05) and condition (F 1,34 = 15.90, p < .05) and a significant treatment × condition interaction (F 1,34 = 17.16, p < .05; Fig. 3D ). The post hoc comparisons indicated that the intra-VH spantide injections significantly reduced the duration of PSF compared with the pre-injection condition and the PBS group. The same groups of rats that received spantide (100 pmol/0.2 μL) or PBS injections in the VH and were exposed to dPAG-ES were subjected to the EPM test 1 and 7 days later. Independent no-ES (SHAM) groups were used as controls for this test. The one-way ANOVA revealed significant differences in the number of open-arm entries (F 2,26 = 8.57, p < .05) and percent time spent on the open arms relative to total time (F 2,26 = 3.75, p < .05) in the groups of rats that were tested 1 day after dPAG-ES. The post hoc comparisons indicated that the PBS-1 day group made fewer open-arm entries and exhibited a decrease in the percent time spent on the open arms compared with the SHAM group. Interestingly, spantide treatment prevented these effects ( Fig. 3E and G , respectively) . This analysis also revealed no significant differences in the number of closed-arm entries (F 2,26 = 1.75, p > .05; Fig. 3F ). The one-way ANOVA that was applied to the data from the 7-day groups revealed significant differences in the number of open-arm entries (F 2,21 = 3.91, p < .05) and percent time spent on the open arms relative to total time (F 2,21 = 3.69, p < .05). The post hoc comparisons indicated that the PBS-7 days and spantide-7 days groups made fewer open-arm entries and exhibited a decrease in the percent time spent on the open arms compared with the SHAM group (Fig. 3H and J, respectively). This analysis also revealed no significant differences in the number of closed-arm entries (F 2,21 = 0.22, p > .05; Fig. 3I ). 
Table 1
Mean ± SEM of freezing and escape thresholds (μA) and duration of post-stimulation freezing (PSF; in seconds) in rats that received electrical stimulation of the dorsal periaqueductal gray 1, 7, and 14 days (d) before the EPM test. n = 8 for 1 d; n = 7 for 7 d; n = 7 for 14 d.
Group
Freezing ( Table 2 Mean ± SEM of open-and closed-arm entries and percent time spent on the open arms (OA) relative to total time in SHAM (no-ES) rats that were used as controls for the groups that underwent the EPM test 1, 7, and 14 days (d) after electrical stimulation of the dorsal periaqueductal gray. n = 5 per group.
Open arms Closed arms % OA time/total 1 d 4.80 ± 0.4 13.0 ± 1.9 18.7 ± 2.0 7 d 3.80 ± 0.9 12.8 ± 2.0 11.8 ± 4.4 14 d 3.60 ± 0.9 16.6 ± 0.9 10.0 ± 3.9
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Only rats in which the tips of the electrodes were located within the dPAG and the injection needles were within the CeA were used in this study (Fig. 1C) . Two-way repeated-measures ANOVA was used to assess the effects of the drug injections in the CeA on defensive responses (freezing and escape and PSF time) that were induced by dPAG-ES, with treatment (PBS and spantide) and condition (pre-and post-injection) as factors. To the freezing threshold data, the two-way repeated-measures ANOVA revealed no significant effects of treatment (F 1,26 = 0.61, p > .05) or condition (F 1,26 = 3.77, p > .05) on freezing thresholds and no treatment × condition interaction (F 1,26 = 0.77, p > .05; Fig. 4B ). The same analysis revealed no significant effects of condition (F 1,26 = 2.25, p > .05) or treatment (F 1,26 = 1.35, p > .05) on escape thresholds and no treatment × condition interaction (F 1,26 = 1.26, p > .05; Fig. 4C ). However, the same analysis that was performed for the duration of PSF when dPAG-ES at the escape threshold had ceased revealed significant effects of treatment (F 1,26 = 3.73, p < .05) and condition (F 1,26 = 26.22, p < .05) and a significant treatment × condition interaction (F 1,26 = 28.64, p < .05). The post hoc comparisons indicated that intra-CeA spantide injections significantly reduced the duration of PSF compared with the pre-injection condition and the PBS group (Fig. 4D) .
The same groups of rats that received spantide (100 pmol/0.2 μL) or PBS injections in the CeA and were subjected to dPAG-ES underwent the EPM test 1 and 7 days later. Independent no-ES (SHAM) groups were used as controls for this test. The one-way ANOVA revealed significant differences in the number of open-arm entries (F 2,19 = 10.91, p < .05) and percent time spent on the open arms relative to total time (F 2,19 = 7.26, p < .05) in the groups of rats that were tested 1 day after dPAG-ES. The post hoc comparisons revealed that the PBS-1 day group made fewer open-arm entries and exhibited a decrease in the percent time spent on open arms compared with the SHAM (no-ES) group. Interestingly, spantide treatment prevented these effects ( Fig. 4E and G , respectively) . This analysis also revealed no significant differences in the number of closed-arm entries (F 2,19 = 2.62, p > .05; Fig. 4F ). The one-way ANOVA that was applied to the data from the 7-day groups revealed that spantide did not reverse the aversive effects of dPAG-ES as observed in the 1-day group. Significant differences were observed in the number of open-arm entries (F 2,19 = 6.99, p < .05) and percent time spent on the open arms relative to total time (F 2,19 = 4.90, p < .05). The post hoc comparisons indicated that the PBS-7 days and spantide-7 days groups made fewer open-arm entries and exhibited a decrease in the percent time spent on the open arms compared with the SHAM (no-ES) group (Fig. 4H and J, respectively) . This analysis also revealed no significant differences in the number of closed-arm entries (F 2,19 = 0.89, p > .05; Fig. 4I ).
Discussion
The primary findings of the present study were that a traumatic experience that was caused by dPAG-ES had lasting consequences on exploratory behavior in rats in the EPM. Rats that received dPAG stimulation exhibited a reduction of exploration of the open arms in the EPM up to 14 days after stimulation. Although spantide infusions in the VH and CeA did not alter the aversive freezing and escape thresholds, it reduced PSF and attenuated the consequences of dPAG-ES on behavior in the EPM 1 day but not 7 days later. These findings suggest that the role of NK1 receptors in these structures in the generation of behavioral sensitization that is triggered by dPAG-ES lasts for at least 1 day.
The participation of neurokininergic systems in distinct hippocampal regions in the expression of defensive behaviors (Borelli, Defensor, Blanchard, Blanchard, & Griebel, 2010; Carvalho, Masson, Brandao, & de Souza Silva, 2008; Duarte et al., 2014) and promnesticlike effects has been demonstrated in several studies (Huston & Hasenohrl, 1995; Kart et al., 2004; Schable et al., 2011) . The present study found clear evidence of the role of hippocampal and amygdalar NK1 receptors in encoding long-term fear memory. We also found evidence of an important role for these receptors in the VH in the evaluation of aversive information that is triggered by dPAG-ES that is transmitted to prosencephalic structures and aids in the recognition of threatening stimuli in fear-experienced animals (Brandao, Zanoveli, Ruiz-Martinez, Oliveira, & Landeira-Fernandez, 2008; Carvalho et al., 2013 Carvalho et al., , 2015 .
When facing a threatening situation, animals tend to present two opposite patterns of defensive reactions. One defensive reaction is related to freezing behavior, in which the animal starts to inhibit its ongoing behavior. The other defensive reaction is related to vigorous escape responses, such as running and jumping ). The dPAG mediates both active and inhibitory behavioral patterns of defensive responses (De Oca, DeCola, Maren, & Fanselow, 1998; Fanselow, 1991) . After these defensive reactions, the animals engage in another type of immobile behavior, as if they were evaluating the consequences of being exposed to a situation that could threaten survival. In the dPAG-ES procedure, the stepwise increase in electrical current elicits a freezing response, followed by vigorous escape reactions (Coimbra & Brandao, 1993; Schenberg, Costa, Borges, & Castro, 1990) . Our findings indicate that these responses are not controlled by NK1 receptors of VH and CeA, since the treatment with spantide in both structures did not cause changes in the freezing and escape thresholds determined by dPAG-ES procedure. In fact, what is know is that these behavioral responses are tonically controlled by γ-aminobutyric acid (GABA)ergic mechanisms at the level of the dPAG (Brandao et al., 1999; Fanselow & Kim, 1992; Jacquet & Squires, 1988) but not amygdala (Martinez et al., 2006) . dPAG-ES at the freezing and escape thresholds activates descending output projections to more caudal brainstem 
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Neurobiology of Learning and Memory 148 (2018) 60-68 structures, such as the cuneiform nucleus (Vianna & Brandao, 2003) . Although in the VH experiment the PBS and SPA groups differed on escape threshold before any drug was applied, the anti-aversive effects of intra-dPAG injections of spantide in rats submitted to the EPM one day later could not be attributed to group difference in sensitivity to shock prior to drug treatment because the SPA group was more sensitive to dPAG-ES (lower escape threshold) compared to the control rats (higher escape threshold), which were to receive PBS. In other words, rats that received SPA treatment were from the group that expressed higher sensitivity to dPAG-ES than the previously determined control group. Even so, rats treated with spantide showed lower reactivity to the aversive stimuli of the EPM one day later.
Although NK1 receptors in the VH and CeA do not appear to play a modulatory role in freezing and escape responses that are evoked by dPAG-ES, they appear to mediate the processing of aversive information that is generated by such stimulation. Post-stimulation freezing is elicited when the flight reaction ceases and is thought to reflect the processing and transfer of information that is coupled to this type of aversive experience to prosencephalic structures, including the amygdala ( M.C. Carvalho et al. Neurobiology of Learning and Memory 148 (2018) 60-68 Nobre, Brandao, & Landeira-Fernandez, 2004 ). The present study extends our previous findings that showed that the CeA, through NK1 receptors, participates in the same processing (Carvalho et al., 2013 (Carvalho et al., , 2015 . Neuroanatomical studies revealed that the hippocampal formation receives direct projections from the amygdala (Pitkanen, Pikkarainen, Nurminen, & Ylinen, 2000) and indirect projections from the dPAG via thalamic nuclei and caudal diencephalic nuclei, such as posterior hypothalamic and supramammillary nuclei (Bland & Oddie, 1998; Krout, Belzer, & Loewy, 2002) . NK1 antagonist infusions in the VH and CeA reduced PSF, suggesting that SP may be released in both structures during the expression of PSF. The inhibition of effects of SP at NK1 receptors by spantide treatment at this prosencephalic level appeared to reduce PSF. Post-stimulation freezing is implicated in the formation of the aversive memory that is triggered by the activation of neural substrates associated with fear (Carvalho et al., 2015) . The antiaversive effects of spantide injections in the VH and CeA on the consequences of dPAG-ES were reflected by PSF, the behavioral sensitization of which was assessed 24 h later in the EPM. Rats that were subjected to dPAG-ES and received vehicle exhibited higher aversion to the open arms of the EPM compared with sham rats that did not receive dPAG-ES. Injections of spantide in the VH prevented the proaversive effects of dPAG-ES on behavior in the EPM 24 h later. The same pattern of responses was observed with local injections of spantide in the CeA, as previously Learning and Memory 148 (2018) 60-68 shown (Carvalho et al., 2015) . Some studies have reported a role for SP in the facilitation of inhibitory drive to hippocampal GABAergic interneurons (Langosch et al., 2005; Ogier & Raggenbass, 2003; Ogier, Wrobel, & Raggenbass, 2008) , and SP may also be implicated in learning and memory processes (Kart et al., 2004; Yu et al., 2014) . NK1 receptors (G-protein-coupled receptors) function via the IP3-signaling system (Taufiq et al., 2005) by two signaling responses (IP3-Ca 2+ and DAG-PKC), both of which are associated with mechanisms that regulate learning and memory, such as long-term potentiation and long-term depression (Myohanen, Venalainen, Garcia-Horsman, & Mannisto, 2008) . Therefore, NK1 receptor antagonism soon after dPAG activation may prevent the long-term storage of aversive information. However, spantide-induced NK1 receptor inhibition in the VH and CeA did not prevent the proaversive effects of dPAG-ES on behavior in the EPM 7 days later. This suggests that the behavioral sensitization occurred even when NK1 receptors were inhibited, indicating that the aversive learning process that is triggered by dPAG-ES does not dependent exclusively on NK1 receptors in these limbic structures. This evidence also suggests that spantide did not exert an amnesic effect but still had actions that occurred through unknown neural mechanisms that lasted for 1 day. Compensatory mechanisms that originated in other structures may have been engaged during the time of PSF when spantide exerted its actions. NK1 receptors in the CeA were shown to mediate this aversive learning process (Carvalho et al., 2015) , with participation of the VH in the retrieval of fear memories (Burman, Starr, & Gewirtz, 2006; Do-Monte, Quinones-Laracuente, & Quirk, 2015) .
The key role of the hippocampus in the regulation of emotions (Eichenbaum, 2000; Engin & Treit, 2007; Squire, Wixted, & Clark, 2007) has been established for more than 30 years (Gray & McNaughton, 1983; Nadel, O'Keefe, & Black, 1975) . Animals with hippocampal damage have difficulty inhibiting previously learned behavioral responses (Gray & McNaughton, 2000) . NK1 receptor inhibition in the VH and CeA reduced PSF and directly influenced exploratory behavior in the EPM 24 h later, indicating that cognition and emotion are interrelated at the VH and CeA levels (Carvalho et al., 2008 (Carvalho et al., , 2013 . Recruitment of the SP-NK1 receptor system appears to occur during aversive situations that trigger the consolidation of fear memories and, consequently, behavioral sensitization such as those that are derived from the activation of neural substrates of fear that is generated in the dPAG. Importantly, our previous studies did not employ dPAG-ES but found that SP in the VH and spantide injections in the CeA did not alter exploratory behavior in the EPM in rats (Bassi, Carvalho, Almada, & Brandao, 2017; Carvalho et al., 2008 Carvalho et al., , 2013 . Thus, the neurokininergic system via SP-NK1 receptors in the VH and CeA may modulate the processing of an aversive stimulus that is triggered by dPAG-ES, thereby strengthening emotional reactions to novel and stressful stimuli that are present in the EPM (Carvalho et al., 2013) . Some studies reported that hippocampal and amygdalar dysfunction increases the valence of negative events, leading to an exaggerated fear response (Hayes, Vanelzakker, & Shin, 2012; Rauch, Shin, & Phelps, 2006) and directly influencing some forms of anxiety disorders (Davidson & Jarrard, 2004; Gray & McNaughton, 1983; McNaughton, 1997; McNaughton & Wickens, 2003) .
In conclusion, the present study provides evidence of the participation of neurokininergic mechanisms via NK1 receptors in the VH and CeA in the processing of aversive information that ascends from the dPAG. NK1 receptor antagonism in the VH and CeA attenuated the proaversive effects of dPAG-ES on behavior in the EPM up to 1 day later. These findings indicate that the SP-NK1 receptor system in the VH participates in the storage of aversive information that originates from the activation of neural substrates in the dPAG associated with aversion. We previously showed that aversiveness of the dPAG-ES has properties that are particular to recruitment of the CeA as the output pathway during its consolidation process (Carvalho et al., 2013 (Carvalho et al., , 2015 . Moreover, the present study elucidated the duration of aversion that is triggered by dPAG-ES and the duration of spantide's antiaversive effects. Aversion that is generated by dPAG-ES is prolonged and can last up to 14 days. The SP-NK1 receptor system appears to play a crucial role in the processing of aversive information that is generated within the dPAG and sent toward higher brain structures that are responsible for the storage of memories of intense threatening stimuli within a given time window. Indeed, the VH and CeA appear to be crucial for both encoding and retrieving distinct classes of learned fear (Gross & Canteras, 2012) . Therefore, neural circuitry that involves the VH and CeA via SP-NK1 receptors appears to mediate emotional and cognitive aspects of the defensive reaction that is generated by dPAG-ES, which could be related to long-term memories of intense threatening conditions, similar to what occurs in PTSD.
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